Atavistik Bio gathers $60m Series A
Atavistik Bio, a pre-clinical biotechnology company, has raised $60 million in Series A financing.
Atavistik Bio, a pre-clinical biotechnology company, has raised $60 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination